Sort
15,273 grants matching “antimicrobial resistance”
Phase 2 Study of PA-824 for Treatment of Pulmonary Tuberculosis
$400,000Kelly E. Dooley · Johns Hopkins University · R01 · FY2017 · FD
Modulation of Inflammasome Activation by Yersinia
$400,000Igor E Brodsky · University Of Pennsylvania · R01 · FY2016 · AI
A NOVEL REGULATOR OF CORNEAL WOUND HEALING
$400,000Feng Lin · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · EY
RESPIRATORY PATHOGENS RESEARCH CENTERS (RPRC)
$400,000David Topham · University Of Rochester · N01 · FY2015 · AI
Innate immune-mediated control of pulmonary Legionella pneumophila infection
$400,000Sunny Shin · University Of Pennsylvania · R01 · FY2020 · AI
Modulation of Inflammasome Activation by Yersinia
$400,000Igor E Brodsky · University Of Pennsylvania · R01 · FY2014 · AI
Modulation of Inflammasome Activation by Yersinia
$400,000Igor E Brodsky · University Of Pennsylvania · R01 · FY2015 · AI
Alpha-Defensins in perioperative thrombosis
$400,000Abd Alroof Higazi · University Of Pennsylvania · R01 · FY2017 · HL
CREWS: Chemical Resonance Excitation Wavelength Selection for Label-Free DNA Analysis
$400,000Yeshaiahu Fainman · University Of California-San Diego · · FY2017 · ENG
Alpha-Defensins in perioperative thrombosis
$400,000Abd Alroof Higazi · University Of Pennsylvania · R01 · FY2015 · HL
Innate immune-mediated control of pulmonary Legionella pneumophila infection
$400,000Sunny Shin · University Of Pennsylvania · R01 · FY2019 · AI
Calcium Dependent Signaling in Airway Epithelial Cells
$400,000Alice S Prince · Columbia University Health Sciences · R01 · FY2016 · HL
Innate immune-mediated control of pulmonary Legionella pneumophila infection
$400,000Sunny Shin · University Of Pennsylvania · R01 · FY2016 · AI
Phase 2 Study of PA-824 for Treatment of Pulmonary Tuberculosis
$400,000Kelly E. Dooley · Johns Hopkins University · R01 · FY2018 · FD
Task D05: Nonclinical Services for the Development of Interventional Agents for Infectious Diseases
$400,000Jon Mirsalis · Sri International · N01 · FY2020 · AI
Role of type III interferons in Staphylococcus aureus respiratory tract infection
$400,000Dane Parker · Columbia University Health Sciences · R01 · FY2017 · HL
Innate immune-mediated control of pulmonary Legionella pneumophila infection
$400,000Sunny Shin · University Of Pennsylvania · R01 · FY2017 · AI
Epithelial mechanisms of inducible resistance to AML-associated pneumonia
$400,000Scott E. Evans · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · HL
Epithelial mechanisms of inducible resistance to AML-associated pneumonia
$400,000Scott E. Evans · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · HL
Alpha-Defensins in perioperative thrombosis
$400,000Abd Alroof Higazi · University Of Pennsylvania · R01 · FY2016 · HL
Phase 2 Study of PA-824 for Treatment of Pulmonary Tuberculosis
$400,000Kelly E. Dooley · Johns Hopkins University · R01 · FY2015 · FD
Negative regulation of C-type lectin receptor signaling in response to fungal infection
$400,000Haoqiang Ying · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · AI
Negative regulation of C-type lectin receptor signaling in response to fungal infection
$400,000Mien-Chie Hung · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · AI
Negative regulation of C-type lectin receptor signaling in response to fungal infection
$400,000Haoqiang Ying · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · AI
Phase 2 Study of PA-824 for Treatment of Pulmonary Tuberculosis
$400,000Kelly E. Dooley · Johns Hopkins University · R01 · FY2014 · FD